Citation: | YU Qiong, LI Jianying, CAO Puli, LIU Dong, ZHANG Jian, LI Ruifeng. Prevalence of non-alcoholic fatty liver disease and associated factors in overweight and obese children in Hohhot[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2024, 45(5): 742-745. doi: 10.16835/j.cnki.1000-9817.2024142 |
[1] |
DIEHL A M, DAY C. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis[J]. N Engl J Med, 2017, 377(21): 2063-2072. doi: 10.1056/NEJMra1503519
|
[2] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 实用肝脏病杂志, 2018, 21(2): 177-186. https://www.cnki.com.cn/Article/CJFDTOTAL-CRBX201805002.htm
Fatty Liver and Alcoholic Liver Disease Group of Hepatology Branch of Chinese Medical Association, Fatty Liver Expert Committee of Chinese Medical Association. Guidelines for the prevention and treatment of non-alcoholic fatty liver disease (2018 update)[J]. J Pract Liver Dis, 2018, 21(2): 177-186. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-CRBX201805002.htm
|
[3] |
RIAZI K, AZHARI H, CHARETTE J H, et al. The prevalence and incidence of NAFLD worldwide: a systematic review and Meta-analysis[J]. Lancet Gastroenterol Hepatol, 2022, 7(9): 851-861. doi: 10.1016/S2468-1253(22)00165-0
|
[4] |
ZHOU J, ZHOU F, WANG W, et al. Epidemiological features of NAF-LD from 1999 to 2018 in China[J]. Hepatology, 2020, 71(5): 1851-1864. doi: 10.1002/hep.31150
|
[5] |
ESTES C, ANSTEE Q M, ARIAS-LOSTE M T, et al. Modeling NAF-LD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030[J]. J Hepatol, 2018, 69(4): 896-904. doi: 10.1016/j.jhep.2018.05.036
|
[6] |
NOBILI V, ALISI A, VALENTI L, et al. NAFLD in children: new genes, new diagnostic modalities and new drugs[J]. Nat Rev Gastroenterol Hepatol, 2019, 16(9): 517-530. doi: 10.1038/s41575-019-0169-z
|
[7] |
吴敏, 陈联辉, 陈郎湖, 等. 心磷脂变化参与非酒精性脂肪性肝病相关线粒体功能障碍的发生和发展[J]. 中南大学学报(医学版), 2021, 46(6): 653-657. https://www.cnki.com.cn/Article/CJFDTOTAL-HNYD202106014.htm
WU M, CHEN L H, CHEN L H, et al. Cardiolipin changes are involved in the onset and development of mitochondrial dysfunction associated with nonalcoholic fatty liver disease[J]. J Central South Univ (Med Edit), 2021, 46(6): 653-657. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-HNYD202106014.htm
|
[8] |
中华人民共和国国家卫生健康委员会. 学龄儿童青少年超重与肥胖筛查:
WS/T 586—2018[S]. 2018-08-01. National Health Commission of the PRC. Screening for overweight and obesity in school-age children and adolescents: WS/T 586-2018[S]. 2018-08-01. (in Chinese)
|
[9] |
周雪莲, 傅君芬. 儿童非酒精性脂肪肝病诊断与治疗专家共识[J]. 中国实用儿科杂志, 2018, 33(7): 487-492. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201807002.htm
ZHOU X L, FU J F. Expert consensus on diagnosis and treatment of non-alcoholic fatty liver disease in children[J]. Chin J Pract Paediatr, 2018, 33(7): 487-492. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK201807002.htm
|
[10] |
SHAUNAK M, BYRNE C D, DAVIS N, et al. Non-alcoholic fatty liver disease and childhood obesity[J]. Arch Dis Child, 2021, 106(1): 3-8. doi: 10.1136/archdischild-2019-318063
|
[11] |
杨田, 张凯文, 高昇, 等. 内蒙古地区学生肥胖现状及影响因素分析[J]. 中国学校卫生, 2021, 42(4): 611-614. doi: 10.16835/j.cnki.1000-9817.2021.04.030
YANG T, ZHANG K W, GAO S, et al. Analysis of obesity status and influencing factors of students in Inner Mongolia[J]. Chin J Sch Health, 2021, 42(4): 611-614. (in Chinese) doi: 10.16835/j.cnki.1000-9817.2021.04.030
|
[12] |
中华人民共和国国家卫生健康委员会. 中国居民营养与慢性病状况报告(2020年)[J]. 营养学报, 2020, 42(6): 521. https://www.cnki.com.cn/Article/CJFDTOTAL-CZSJ202114035.htm
National Health Commission of the PRC. Report on nutrition and chronic disease status of Chinese residents (2020)[J]. J Nutr, 2020, 42(6): 521. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-CZSJ202114035.htm
|
[13] |
陈新春, 寇永妹, 刘晓璐, 等. 唐山市7~14岁肥胖儿童非酒精性脂肪肝流行现状及危险因素初步分析[J]. 中国儿童保健杂志, 2021, 29(6): 669-673. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202106023.htm
CHEN X C, KOU Y M, LIU X L, et al. Preliminary analysis of the prevalence and risk factors of non-alcoholic fatty liver disease in obese children aged 7-14 years in Tangshan City[J]. Chin J Child Health, 2021, 29(6): 669-673. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202106023.htm
|
[14] |
蒋雪, 高健, 洪泽, 等. 维生素D治疗肥胖合并非酒精性脂肪肝儿童的临床研究[J]. 中国儿童保健杂志, 2022, 30(9): 970-974. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202209009.htm
JIANG X, GAO J, HONG Z, et al. Clinical study of vitamin D treatment in children with obesity combined with non-alcoholic fatty liver disease[J]. Chin J Child Health, 2022, 30(9): 970-974. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202209009.htm
|
[15] |
王雨, 杨志然, 陈润花. 中国儿童非酒精性脂肪性肝病患病率的Meta分析[J]. 中国儿童保健杂志, 2022, 30(7): 764-769. https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202207015.htm
WANG Y, YANG Z R, CHEN R H. Meta-analysis of the prevalence of non-alcoholic fatty liver disease in Chinese children[J]. Chin J Child Health, 2022, 30(7): 764-769. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ERTO202207015.htm
|
[16] |
ANDERSON E L, HOWE L D, JONES H E, et al. The prevalence of non-alcoholic fatty liver disease in children and adolescents: a systematic review and Meta-analysis[J]. PLoS One, 2015, 10(10): e0140908.
|
[17] |
李东丹, 闫洁, 王美辰, 等. 非酒精性脂肪性肝病肥胖儿童人体成分及其影响因素分析[J]. 中国实用儿科杂志, 2023, 38(7): 525-529. https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK202307010.htm
LI D D, YAN J, WANG M C, et al. Analysis of body composition and its influencing factors in obese children with non-alcoholic fatty liver disease[J]. Chin J Pract Paediatr, 2023, 38(7): 525-529. (in Chinese) https://www.cnki.com.cn/Article/CJFDTOTAL-ZSEK202307010.htm
|
[18] |
杨青华, 代东伶. 儿童NAFLD的危险因素分析[C]//中国中西医结合学会儿科专业委员会. 第二十三次全国儿科中西医结合学术会议资料汇编. 深圳: 深圳市儿童医院, 2019.
YANG Q H, DAI D L. Analysis of risk factors for NAFLD in children[C]//Pediatrics Committee of the Chinese Society of Integrative Medicine. Compilation of materials of the 23rd National Academic Conference on Integrative Medicine in Paediatrics. Shenzhen: Shenzhen Children's Hospital, 2019. (in Chinese)
|
[19] |
SUN Q, ZHANG T, MANJI L, et al. Association between serum uric acid and non-alcoholic fatty liver disease: an updated systematic review and Meta-analysis[J]. Clin Epidemiol, 2023, 15: 683-693.
|
[20] |
LANASPA M A, SANCHEZ-LOZADA L G, CHOI Y J, et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-dependent and-independent fatty liver[J]. J Biol Chem, 2012, 287(48): 40732-40744.
|